Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.2 was added; the prior notices about funding and government status (v3.4.1) were removed.SummaryDifference0.4%

- Check12 days agoChange DetectedAdded a government funding lapse notice about site operation and potential processing delays. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check19 days agoChange DetectedUI updates include showing the glossary toggle, adding the 'Last Update Submitted that Met QC Criteria' label, and updating the revision tag to 'Revision: v3.4.0'. Capitalization changes such as 'No FEAR Act Data' and the removal of the older 'Revision: v3.3.4' reference are also present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check33 days agoChange DetectedFooter revision tag updated to v3.3.4, replacing the previous v3.3.3 tag. No other page content or study details appear to be changed.SummaryDifference0.0%

- Check55 days agoChange DetectedThe Locations section is expanded to include multiple Chinese sites (Beijing Municipality, Heilongjiang, Henan, Hubei, Hunan, Jiangsu, Jiangxi, Jilin, Liaoning, Ningxia, Shanxi, Sichuan, Tianjin Municipality, Zhejiang). Individual province location subsections were removed or reorganized, consolidating site information under the new Locations heading.SummaryDifference2%

- Check84 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.